Alkermes
ALKS
#2795
Rank
S$7.46 B
Marketcap
S$44.79
Share price
-0.60%
Change (1 day)
2.74%
Change (1 year)

P/E ratio for Alkermes (ALKS)

P/E ratio as of April 2026 (TTM): 16.8

According to Alkermes's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.8309. At the end of 2024 the company had a P/E ratio of 12.9.

P/E ratio history for Alkermes from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202412.9-0.04%
202312.9-147.4%
2022-27.2-64.89%
2021-77.5172.37%
2020-28.575.82%
2019-16.2
2017-53.130.98%
2016-40.6-22.32%
2015-52.2-82.16%
2014-293

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
21.8 29.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
21.4 27.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
20.8 23.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
23.2 37.78%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
17.2 2.34%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
34.3 103.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-6.56-138.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-0.0676-100.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
24.3 44.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.